Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Novartis AG's top 10 drugs based on revenue in 2017 (in million U.S. dollars)

Exclusive Premium Statistic

Novartis' top drugs based on revenue 2017 This statistic depicts Novartis AG's top 10 drugs based on revenue in 2017. Novartis is a Swiss-based global pharmaceutical company. In that year, Novartis' drug Tasigna generated some 1.84 billion U.S. dollars of revenue. Since several years, Gleevec (glivec) is one of Novartis' top pharmaceutical product based on revenue. Gleevec is a drug for the treatment of several types of cancer.
Show more
Exclusive Premium statistic

Get a Premium Account for unrestrained access.
Benefits of our Premium membership:

  • Access to all Premium statistics
  • Download as XLS, PNG and PDF
  • Detailed source and background information
Premium Account
$49 per month*
(billed annually)
*Single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

View price details

Revenue in million U.S. dollars
--
--
--
--
--
--
--
--
--
--
Revenue in million U.S. dollars
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

Get a Premium Account for unrestrained access.
Benefits of our Premium membership:

  • Access to all Premium statistics
  • Download as XLS, PNG and PDF
  • Detailed source and background information
Premium Account
$49 per month*
(billed annually)
*Single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

View price details

© Statista 2018

Download Settings Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Description Source More information
This statistic depicts Novartis AG's top 10 drugs based on revenue in 2017. Novartis is a Swiss-based global pharmaceutical company. In that year, Novartis' drug Tasigna generated some 1.84 billion U.S. dollars of revenue. Since several years, Gleevec (glivec) is one of Novartis' top pharmaceutical product based on revenue. Gleevec is a drug for the treatment of several types of cancer.
Show more
Release date
January 2018
Region
Worldwide
Survey time period
2017
Open this statistic in...

Statista Accounts: Access All Statistics. Starting from $588 / Year

Leading companies trust Statista:

Related Studies: Available to Download in PDF or PPTX Format

Novartis

All Information
in one Presentation

Novartis

Everything On "Novartis" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Other Reports & Dossiers
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Novartis"

  • Global positioning
  • Company overview
  • Revenue distribution
  • Research and development
The most important statistics
  • Miscellaneous
The most important statistics
Statista for your company

Saves time and money: instant access to this and 1 million more statistics.
Access to dossiers, industry reports and many other studies.

Need help with using Statista for your research? Tutorials and first steps

Further Content: Statistics, Studies, and Topic Pages

Statistics on the topic

Topics

About Statista

Learn more about how Statista can support your business.

Request webinar
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.